1. |
Guenther T, Noebauer C, Mazzitelli D, et al. Tricuspid valve surgery: a thirty-year assessment of early and late outcome. Eur J Cardiothorac Surg, 2008, 34(2): 402-409.
|
2. |
Lurz P, Stephan von Bardeleben R, Weber M, et al. Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation. J Am Coll Cardiol, 2021, 77(3): 229-239.
|
3. |
Kodali S, Hahn RT, Eleid MF, et al. Feasibility study of the transcatheter valve repair system for severe tricuspid regurgitation. J Am Coll Cardiol, 2021, 77(4): 345-356.
|
4. |
Topilsky Y, Maltais S, Medina Inojosa J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging, 2019, 12(3): 433-442.
|
5. |
Yang L, Chen H, Pan W, et al. Analyses for prevalence and outcome of tricuspid regurgitation in China: an echocardiography study of 134, 874 patients. Cardiology, 2019, 142(1): 40-46.
|
6. |
中国医师协会超声医师分会心脏超声专业委员会, 中国医师协会心血管病分会结构性心脏病专业委员会. 三尖瓣反流介入治疗的超声心动图评价中国专家共识(2021 版). 中华超声影像学杂志, 2021, 30(6): 461-471.
|
7. |
姚静, 龚婵娟, 孔祥清. 三尖瓣反流介入治疗的研究进展. 中华心血管病杂志, 2019, 47(7): 577-580.
|
8. |
Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Am Soc Echocardiogr, 2017, 30(4): 303-371.
|
9. |
Writing Committee Members, Otto CM, Nishimura RA, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol, 2021, 77(4): e25-e197.
|
10. |
Kowalski M, Franz N, Ritter F, et al. Simultaneous transfemoral transcatheter mitral and tricuspid valve edge-to-edge repair (using MitraClip system) completed by atrial septal defect occlusion in a surgically inoperable patient. First-in-human report. Kardiochir Torakochirurgia Pol, 2015, 12(4): 295-297.
|
11. |
Schofer J, Tiburtius C, Hammerstingl C, et al. Transfemoral tricuspid valve repair using a percutaneous mitral valve repair system. J Am Coll Cardiol, 2016, 67(7): 889-890.
|
12. |
Wengenmayer T, Zehender M, Bothe W, et al. First transfemoral percutaneous edge-to-edge repair of the tricuspid valve using the MitraClip system. EuroIntervention, 2016, 11(13): 1541-1544.
|
13. |
Hammerstingl C, Schueler R, Malasa M, et al. Transcatheter treatment of severe tricuspid regurgitation with the MitraClip system. Eur Heart J, 2016, 37(10): 849-853.
|
14. |
Sorajja P, Cavalcante JL, Gossl M, et al. Transcatheter repair of tricuspid regurgitation with mitraclip. Prog Cardiovasc Dis, 2019, 62(6): 488-492.
|
15. |
Taramasso M, Alessandrini H, Latib A, et al. Outcomes after current transcatheter tricuspid valve intervention: mid-term results from the international trivalve registry. JACC Cardiovasc Interv, 2019, 12(2): 155-165.
|
16. |
Mehr M, Taramasso M, Besler C, et al. 1-year outcomes after edge-to-edge valve repair for symptomatic tricuspid regurgitation: results from the TriValve Registry. JACC Cardiovasc Interv, 2019, 12(15): 1451-1461.
|
17. |
Nickenig G, Weber M, Lurz P, et al. Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study. Lancet, 2019, 394(10213): 2002-2011.
|
18. |
Fam NP, Braun D, von Bardeleben RS, et al. Compassionate use of the PASCAL transcatheter valve repair system for severe tricuspid regurgitation: a multicenter, observational, first-in-human experience. JACC Cardiovasc Interv, 2019, 12(24): 2488-2495.
|
19. |
Kitamura M, Fam NP, Braun D, et al. 12-month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation. Catheter Cardiovasc Interv, 2021, 97(6): 1281-1289.
|
20. |
Aurich M, Volz MJ, Mereles D, et al. Initial experience with the PASCAL Ace implant system for treatment of severe tricuspid regurgitation. Circ Cardiovasc Interv, 2021: CIRCINTERVENTIONS121010770.
|
21. |
陈茂, 荆志成, 张浩, 等. 经导管三尖瓣置换治疗的现状与挑战. 中华心血管病杂志, 2021, 49(5): 420-424.
|
22. |
潘文志, 龙愉良, 周达新, 等. 2020 年经导管瓣膜治疗主要进展. 中国胸心血管外科临床杂志, 2021, 28(4): 371-375.
|
23. |
安朝, 陆方林. 2019 年三尖瓣介入治疗的新进展. 中华心血管病杂志(网络版), 2020, 3(1): 1-7.
|
24. |
Chang CC, Veen KM, Hahn RT, et al. Uncertainties and challenges in surgical and transcatheter tricuspid valve therapy: a state-of-the-art expert review. Eur Heart J, 2020, 41(20): 1932-1940.
|
25. |
Schlotter F, Miura M, Kresoja KP, et al. Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis. Eurolntervention, 2021, 17(14): e343-e352.
|
26. |
Taramasso M, Benfari G, van der Bijl P, et al. Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation. J Am Coll Cardiol, 2019, 74(24): 2998-3008.
|
27. |
Ton-Nu TT, Levine RA, Handschumacher MD, et al. Geometric determinants of functional tricuspid regurgitation: insights from 3-dimensional echocardiography. Circulation, 2006, 114(2): 143-149.
|
28. |
Fukuda S, Saracino G, Matsumura Y, et al. Three-dimensional geometry of the tricuspid annulus in healthy subjects and in patients with functional tricuspid regurgitation: a real-time, 3-dimensional echocardiographic study. Circulation, 2006, 114(Suppl 1): 1492-1498.
|